Literature DB >> 12954132

Biokinetics of iodide in man: refinement of current ICRP dosimetry models.

L Johansson1, S Leide-Svegborn, S Mattsson, B Nosslin.   

Abstract

A compartmental model describing the distribution and retention of radioactive iodide in thyroid and other organs is presented. The model is developed from published ICRP models. It is designed primarily for radiation dosimetry of iodine radionuclides used in nuclear medicine, but may also be useful for occupational radiation protection. In the proposed model, the distribution of iodide to the thyroid is assumed to be more rapid than in earlier models. Uptakes in stomach wall and salivary glands are considered, and the absorbed doses to these organs calculated. The partitioning of iodide between stomach wall and content is also discussed. Recirculation of organic iodine is also taken into account. Age-dependent half-times for iodide in the thyroid, as well as for organically-bound iodine are presented. The proposed model is applicable for dose estimations with different uptakes in the thyroid as well as for the situation when the thyroid is blocked, completely or incompletely.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12954132     DOI: 10.1089/108497803322285206

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  12 in total

1.  Improved Patient Dosimetry at Radioiodine Therapy by Combining the ICRP Compartment Model and the EANM Pre-Therapeutic Standard Procedure for Benign Thyroid Diseases.

Authors:  Martin Andersson; Sören Mattsson
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-12       Impact factor: 5.555

2.  The route of administration (oral vs intravenous) does not influence dose or outcome in Graves' disease and unifocal autonomy.

Authors:  Peter Schneider; Johannes Biko; Heribert Hänscheid; Stephan Hilliger; Christos Koutsampelas; Michael Kranzfelder; Stephan Ladner; Christoph Reiners
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-10       Impact factor: 9.236

3.  Measurement of the internal dose to families of outpatients treated with 131I for hyperthyroidism.

Authors:  S F Barrington; P Anderson; A G Kettle; R Gadd; W H Thomson; S Batchelor; P J Mountford; L K Harding; M J O'Doherty
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-06       Impact factor: 9.236

4.  Determination of effective half-life of 131I in patients with differentiated thyroid carcinoma: comparison of cystatin C and creatinine-based estimation of renal function.

Authors:  Martin Freesmeyer; Falk Gühne; Christian Kühnel; Thomas Opfermann; Thomas Winkens; Anke Werner
Journal:  Endocrine       Date:  2018-11-01       Impact factor: 3.633

5.  The Influence of H2-Receptor Antagonist Administration to the 24-h Uptake of I-131 in the Thyroid Gland.

Authors:  Andreas Lim; Hendra Budiawan; A Hussein S Kartamihardja
Journal:  Nucl Med Mol Imaging       Date:  2021-01-07

Review 6.  Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a review.

Authors:  Uta Eberlein; Jörn Hendrik Bröer; Charlot Vandevoorde; Paula Santos; Manuel Bardiès; Klaus Bacher; Dietmar Nosske; Michael Lassmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-30       Impact factor: 9.236

7.  The Combination of In vivo (124)I-PET and CT Small Animal Imaging for Evaluation of Thyroid Physiology and Dosimetry.

Authors:  Henrik H El-Ali; Martin Eckerwall; Dorthe Skovgaard; Erik Larsson; Sven-Erik Strand; Andreas Kjaer
Journal:  Diagnostics (Basel)       Date:  2012-06-05

8.  131I age-dependent inhalation dose in Southern Poland from Fukushima accident.

Authors:  K Brudecki; K Szufa; J W Mietelski
Journal:  Radiat Environ Biophys       Date:  2016-12-23       Impact factor: 1.925

9.  Statistical and radiobiological analysis of the so-called thyroid stunning.

Authors:  Stephan Walrand; Michel Hesse; François Jamar
Journal:  EJNMMI Res       Date:  2015-11-19       Impact factor: 3.138

10.  Dosimetric analysis of (123)I, (125)I and (131)I in thyroid follicle models.

Authors:  Anders Josefsson; Eva Forssell-Aronsson
Journal:  EJNMMI Res       Date:  2014-06-11       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.